In HF, SGLT2 inhibitors reduce HF hospitalizations at up to 2 y.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 35914263.
- Also identified by DOI 10.7326/J22-0055.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Zou X, Shi Q, Vandvik PO, et al. <b>Sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysis.</b> Ann Intern Med. 2022;175:851-61. 35404670.